These 10 mid-cap U.S. healthcare companies carry the market's most expensive valuations
Seeking Alpha News (Tue, 2-Jun 10:10 AM ET)
Chemed Insider Makes a Bold Move With a High-Value Stock Sale
TipRanks (Fri, 29-May 10:11 PM ET)
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Globe Newswire (Mon, 18-May 2:24 PM ET)
Chemed Corporation to Present at the 2026 RBC Global Healthcare Conference
Globe Newswire (Wed, 13-May 9:00 AM ET)
Sadness This Mother's Day? VITAS Healthcare Launches Free, Nationwide Mother's Day Grief Helpline
PRNewswire (Tue, 5-May 9:18 AM ET)
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026
Globe Newswire (Tue, 5-May 9:00 AM ET)
Chemed Reports First-Quarter 2026 Results
Globe Newswire (Thu, 23-Apr 4:15 PM ET)
Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement
Globe Newswire (Mon, 13-Apr 8:15 AM ET)
Globe Newswire (Wed, 1-Apr 12:00 PM ET)
Roto-Rooter Completes Acquisitions for Two Significant Territories
Globe Newswire (Wed, 1-Apr 10:17 AM ET)
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Chemed trades on the NYSE stock market under the symbol CHE.
As of June 2, 2026, CHE stock price declined to $417.21 with 160,113 million shares trading.
CHE has a beta of 0.56, meaning it tends to be less sensitive to market movements. CHE has a correlation of 0.04 to the broad based SPY ETF.
CHE has a market cap of $5.54 billion. This is considered a Mid Cap stock.
Last quarter Chemed reported $658 million in Revenue and $5.65 earnings per share. This beat revenue expectation by $9 million and exceeded earnings estimates by $.44.
In the last 3 years, CHE traded as high as $654.62 and as low as $365.21.
The top ETF exchange traded funds that CHE belongs to (by Net Assets): IJH, VTI, VB, SDVY, VBK.
CHE has underperformed the market in the last year with a price return of -27.0% while the SPY ETF gained +30.1%. CHE has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +1.9% and -5.4%, respectively, while the SPY returned +11.0% and +2.8%, respectively.
CHE support price is $415.05 and resistance is $430.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CHE shares will trade within this expected range on the day.